Histology at transurethral resection of bladder tumor and radical cystectomy for bladder cancer: Insights from population-based data.
作者信息
Dyer Tina, Siemens D Robert, Nippak Pria, Meyer Julien, Booth Christopher M
机构信息
Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Kingston, ON, Canada.
School of Health Services Management, Ryerson University, Toronto, ON, Canada.
出版信息
Can Urol Assoc J. 2021 Apr;15(4):138-140. doi: 10.5489/cuaj.6856.
Abstract
摘要
相似文献
1
Histology at transurethral resection of bladder tumor and radical cystectomy for bladder cancer: Insights from population-based data.经尿道膀胱肿瘤切除术和膀胱癌根治性膀胱切除术的组织学：基于人群数据的见解。
Can Urol Assoc J. 2021 Apr;15(4):138-140. doi: 10.5489/cuaj.6856.
2
The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy.经尿道膀胱肿瘤初始切除术或活检诊断膀胱癌变异在根治性膀胱切除术时的敏感性。
J Urol. 2013 Apr;189(4):1263-7. doi: 10.1016/j.juro.2012.10.054. Epub 2012 Oct 17.
3
Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.经尿道膀胱肿瘤切除术和根治性膀胱切除术配对标本中尿路上皮癌的淋巴管浸润情况。
J Urol. 2008 Nov;180(5):1928-32; discussion 1932. doi: 10.1016/j.juro.2008.07.056. Epub 2008 Sep 17.
4
Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.初始活检或膀胱肿瘤经尿道切除术在检测根治性膀胱切除术中组织学变异方面的敏感性。
BMC Urol. 2015 May 30;15:46. doi: 10.1186/s12894-015-0037-2.
5
Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder.膀胱肌层浸润性尿路上皮癌根治性膀胱切除术和膀胱保留治疗的结果
Asian J Surg. 2014 Oct;37(4):184-9. doi: 10.1016/j.asjsur.2014.01.010. Epub 2014 Mar 14.
6
[Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection].[膀胱癌肌层浸润的局部分期：经尿道切除术后3.0T MRI的表现]
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Aug 18;52(4):701-704. doi: 10.19723/j.issn.1671-167X.2020.04.020.
7
Bladder sparing surgery in high-grade bladder cancer.高级别膀胱癌的膀胱保留手术。
Exp Oncol. 2019 Jun;41(2):160-165. doi: 10.32471/exp-oncology.2312-8852.vol-41-no-2.13207.
8
Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?T1期膀胱癌再次经尿道切除术能否筛选出适合立即行膀胱切除术的患者？
J Urol. 2007 Jan;177(1):75-9; discussion 79. doi: 10.1016/j.juro.2006.08.070.
9
Initial results of retrospective study: preoperative transurethral excision plus chemotherapy and radiation therapy and trial of bladder preservation.回顾性研究的初步结果：术前经尿道切除术加化疗和放疗以及膀胱保留试验。
J Egypt Natl Canc Inst. 2007 Jun;19(2):133-46.
引用本文的文献
1
Evaluating the Quality of Primary Transurethral Resection of Bladder Tumor: A Nine-Year Review at a Tertiary Healthcare Center.评估原发性膀胱肿瘤经尿道切除术的质量：在一家三级医疗中心的九年回顾
Cureus. 2024 Aug 29;16(8):e68143. doi: 10.7759/cureus.68143. eCollection 2024 Aug.
2
Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT.影像指导膀胱癌治疗路径再设计：膀胱癌路径 RCT。
Health Technol Assess. 2024 Aug;28(42):1-65. doi: 10.3310/DEHT5407.
3
Prediction of locally advanced bladder tumor using preoperative clinical parameters.利用术前临床参数预测局部晚期膀胱肿瘤
Urol Ann. 2023 Oct-Dec;15(4):412-416. doi: 10.4103/ua.ua_1_23. Epub 2023 Oct 20.
4
Transurethral resection of bladder tumor-based bladder preservation therapy for refractory high risk non-muscle invasive bladder cancer: Current landscape and future directions.基于经尿道膀胱肿瘤切除术的难治性高危非肌层浸润性膀胱癌膀胱保留治疗：现状与未来方向
Front Surg. 2023 Apr 12;10:1143219. doi: 10.3389/fsurg.2023.1143219. eCollection 2023.
5
Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder.吉西他滨和顺铂新辅助化疗联合选择性膀胱保留放化疗治疗肌层浸润性膀胱癌。
Investig Clin Urol. 2022 Mar;63(2):168-174. doi: 10.4111/icu.20210407.
本文引用的文献
1
Canadian Urological Association guideline: Muscle-invasive bladder cancer.加拿大泌尿外科协会指南：肌层浸润性膀胱癌
Can Urol Assoc J. 2019 Aug;13(8):230-238. doi: 10.5489/cuaj.5902.
2
Perioperative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing?普通人群膀胱癌的围手术期化疗：实践模式终于在改变了吗？
Urol Oncol. 2018 Mar;36(3):89.e13-89.e20. doi: 10.1016/j.urolonc.2017.11.015. Epub 2017 Dec 15.
3
Curative therapy for bladder cancer in routine clinical practice: a population-based outcomes study.常规临床实践中膀胱癌的根治性治疗：一项基于人群的结局研究。
Clin Oncol (R Coll Radiol). 2014 Aug;26(8):506-14. doi: 10.1016/j.clon.2014.05.007. Epub 2014 Jun 20.
4
Perioperative chemotherapy for muscle-invasive bladder cancer: A population-based outcomes study.肌层浸润性膀胱癌的围手术期化疗：基于人群的结局研究。
Cancer. 2014 Jun 1;120(11):1630-8. doi: 10.1002/cncr.28510. Epub 2014 Apr 14.
5
Downstaging of TURBT-Based Muscle-Invasive Bladder Cancer by Radical Cystectomy Predicts Better Survival.
ISRN Urol. 2011;2011:458930. doi: 10.5402/2011/458930. Epub 2011 Apr 27.
6
Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer.尿路上皮膀胱癌的组织学变异型及膀胱癌中的非尿路上皮组织学类型。
Can Urol Assoc J. 2009 Dec;3(6 Suppl 4):S193-8. doi: 10.5489/cuaj.1195.
7
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.临床分期与病理分期的差异：对根治性膀胱切除术后预后的影响
Eur Urol. 2007 Jan;51(1):137-49; discussion 149-51. doi: 10.1016/j.eururo.2006.05.021. Epub 2006 Jun 8.
8
The effects of stage divergence on survival after radical cystectomy for urothelial cancer.
Urol Oncol. 2005 Mar-Apr;23(2):77-81. doi: 10.1016/j.urolonc.2004.08.012.
9
Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification.
J Urol. 1991 Jan;145(1):45-50. doi: 10.1016/s0022-5347(17)38244-7.
Zotero 插件